Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 10.03M | $508.0M | 13.69% | +3.20M | 2026-06-30 |
| ORBIMED ADVISORS LLC | 6.78M | $343.0M | 9.25% | -1.18M | 2026-06-30 |
| Polar Capital Holdings Plc | 6.43M | $326.0M | 8.78% | +1.36M | 2026-06-30 |
| BlackRock, Inc. | 4.36M | $221.0M | 5.95% | +675.0K | 2026-06-30 |
| Vestal Point Capital, LP | 4.00M | $203.0M | 5.46% | +750.0K | 2026-06-30 |
| Commodore Capital LP | 3.27M | $166.0M | 4.47% | -- | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.90M | $147.0M | 3.96% | +2.81M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.57M | $130.0M | 3.51% | -- | 2026-06-30 |
| CITADEL ADVISORS LLC | 2.14M | $108.0M | 2.92% | +269.5K | 2026-06-30 |
| Fairmount Funds Management LLC | 1.86M | $94.0M | 2.53% | -- | 2026-06-30 |
